s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
424B3
Prospectus filed pursuant to Rule 424(b)(3)
Filed
Monday, February 8, 2021
Accession number
0001493152-21-002966
Documents
form424b3.htm
424B3
On sec.gov
Filing index
All files
Complete submission text
SGML header